Amgen's strategy includes a set of integrated activities intended to maintain and strengthen its competitive position in the biotechnology industry. The company has committed to a more agile and efficient operating model through transformation and process improvement efforts, enabling the reallocation of resources to fund innovative pipeline and growth opportunities that deliver value to patients and stockholders. These transformation efforts have realized approximately $1.9 billion in savings, which have been reinvested in product launches, clinical programs, and external business development. The company continues to invest in external innovation to augment its internal innovation, focusing on genetically related investments and genetically validated targets. Amgen's operational efficiency is supported by its next-generation biomanufacturing capabilities, which require a smaller manufacturing footprint and offer greater environmental benefits, including reduced consumption of water and energy and lower levels of carbon emissions. The company’s investments in research and development activities are substantial, reflecting its commitment to discovering, developing, and commercializing innovative products. Amgen's ability to leverage its IT capabilities effectively supports its business needs and enhances its competitive advantage. The company is also focused on optimizing long- and short-term growth through productivity initiatives that enable investment in new products and the defense of existing products. The operational flexibility and strategic resource allocation are critical for Amgen to respond to market dynamics and competitive pressures, particularly as certain products face increasing competition from biosimilars and generics. The company has established a robust framework for information management, ensuring data accuracy, reliability, and security, which is essential for making informed strategic decisions. Amgen's financial performance is closely tied to its ability to manage operational processes and maintain effective governance structures that support its business objectives. The company’s commitment to innovation and process optimization is evident in its ongoing investments in technology infrastructure and capabilities, which facilitate the efficient management of its resources and enhance its organizational effectiveness. Overall, Amgen's focus on integrating its IT capabilities with its business strategies is fundamental to its long-term success and ability to navigate the complexities of the biotechnology landscape.